"Das AGAPLESION KRANKENHAUS NEU BETHLEHEM freut sich uns über 125 Jahre Gesundheitsversorgung in Göttingen und der ländlichen Umgebung. Mehr als 50.000 Göttingerinnen und Göttinger aus Stadt und Landkreis haben hier seitdem das Licht der Welt erblickt und unzählige Patientinnen und Patienten wurden in den verschiedenen Fachabteilungen nach höchsten medizinischen Standards behandelt. Das AGAPLESION KRANKENHAUS NEU BETHLEHEM ist heute eine moderne Gesundheitseinrichtung, die Spitzenmedizin mit besonderer menschlicher Zuwendung verknüpft. Rund um das Krankenhaus haben sich in den vergangenen Jahre zahlreiche medizinische Versorgungseinrichtungen und Facharztpraxen angesiedelt."

During the past decade, Krankenhaus Neu-Bethlehem conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Neu-Bethlehem" #1 collaborator was "Medtronic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Krankenhaus Neu-Bethlehem" are "Heart Failure" (2 trials), "AV Block" (1 trials), "Atrial Arrhythmia" (1 trials), "Renal Artery Stenosis" (1 trials) and "Sinus Node Disease" (1 trials). Many other conditions were trialed in "Krankenhaus Neu-Bethlehem" in a lesser frequency.

Most popular intervention types in "Krankenhaus Neu-Bethlehem" are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "External Electrocardioversion" (1 trials), "Formula PTX Stent - Dose 1" (1 trials), "Formula PTX Stent - Dose 2" (1 trials), "Formula PTX Stent - Dose 3" (1 trials) and "Internal Electrocardioversion" (1 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus Neu-Bethlehem" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Krankenhaus Neu-Bethlehem". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Krankenhaus Neu-Bethlehem, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus Neu-Bethlehem, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Krankenhaus Neu-Bethlehem has several departments that took part in Clinical trials: "Herzkatheterlabor der Kardiologischen Praxis am Krankenhaus Neu-Bethlehem gGmbH" - 2 trials